Pfizer, J&J and Amgen Lead New York Life Trust’s Biggest Healthcare Share Holdings

Wall St. Watchdog reveals information regarding New York Life Trust Co’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 29 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $6.761 million.

  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, New York Life Trust Co reported holding 60,225 shares with a market value of $1,240,635. This comprised 1.49% of the total portfolio. On 09/30/2011, New York Life Trust Co reported holding 57,164 shares with a market value of $1,010,660. This comprised 1.8% of the total portfolio. The net change in shares for this position over the two quarters is -3,061. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, New York Life Trust Co reported holding 15,316 shares with a market value of $1,018,820. This comprised 1.22% of the total portfolio. On 09/30/2011, New York Life Trust Co reported holding 9,922 shares with a market value of $631,932. This comprised 1.13% of the total portfolio. The net change in shares for this position over the two quarters is -5,394. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, New York Life Trust Co reported holding 8,442 shares with a market value of $492,591. This comprised 0.59% of the total portfolio. On 09/30/2011, New York Life Trust Co reported holding 9,748 shares with a market value of $535,750. This comprised 0.95% of the total portfolio. The net change in shares for this position over the two quarters is 1,306. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, New York Life Trust Co reported holding 15,733 shares with a market value of $811,508. This comprised 0.98% of the total portfolio. On 09/30/2011, New York Life Trust Co reported holding 11,404 shares with a market value of $525,952. This comprised 0.94% of the total portfolio. The net change in shares for this position over the two quarters is -4,329. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, New York Life Trust Co reported holding 17,869 shares with a market value of $670,624. This comprised 0.81% of the total portfolio. On 09/30/2011, New York Life Trust Co reported holding 12,996 shares with a market value of $480,462. This comprised 0.86% of the total portfolio. The net change in shares for this position over the two quarters is -4,873. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Gilead Sciences Inc. (NASDAQ:GILD): On 06/30/2011, New York Life Trust Co reported holding 14,843 shares with a market value of $614,649. This comprised 0.74% of the total portfolio. On 09/30/2011, New York Life Trust Co reported holding 11,489 shares with a market value of $445,773. This comprised 0.79% of the total portfolio. The net change in shares for this position over the two quarters is -3,354. About Company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
  • Biogen Idec Inc. (NASDAQ:BIIB): On 06/30/2011, New York Life Trust Co reported holding 4,305 shares with a market value of $460,291. This comprised 0.55% of the total portfolio. On 09/30/2011, New York Life Trust Co reported holding 4,276 shares with a market value of $398,309. This comprised 0.71% of the total portfolio. The net change in shares for this position over the two quarters is -29. About Company: Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company’s products addresses diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis.
  • Wellpoint Inc. (NYSE:WLP): On 06/30/2011, New York Life Trust Co reported holding 7,836 shares with a market value of $617,242. This comprised 0.74% of the total portfolio. On 09/30/2011, New York Life Trust Co reported holding 5,864 shares with a market value of $382,802. This comprised 0.68% of the total portfolio. The net change in shares for this position over the two quarters is -1,972. About Company: WellPoint Inc. is a health benefits company. The Company provides health benefits, dental and vision benefits, pharmacy benefits, life insurance, and life and disability insurance benefits. WellPoint operations include Blue Cross and Blue Shield plans.
  • Humana Inc. (NYSE:HUM): On 06/30/2011, New York Life Trust Co reported holding 5,755 shares with a market value of $463,508. This comprised 0.56% of the total portfolio. On 09/30/2011, New York Life Trust Co reported holding 4,442 shares with a market value of $323,067. This comprised 0.58% of the total portfolio. The net change in shares for this position over the two quarters is -1,313. About Company: Humana Inc. is a managed health care company with medical members located in the United States and Puerto Rico. The Company offers coordinated health care through health maintenance organizations, preferred provider organizations, point-of-service plans, and administrative services products. Humana offers its products to employer groups, government-sponsored plans, and individuals.
  • Covidien Plc (NYSE:COV): On 06/30/2011, New York Life Trust Co reported holding 5,584 shares with a market value of $297,236. This comprised 0.36% of the total portfolio. On 09/30/2011, New York Life Trust Co reported holding 6,060 shares with a market value of $267,246. This comprised 0.48% of the total portfolio. The net change in shares for this position over the two quarters is 476. About Company: Covidien PLC is a global healthcare products company. The Company develops, manufactures and distributes a diverse range of medical devices and supplies, diagnostics imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.

(Note: Data regarding New York Life Trust Co’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>